Effect of intravenous fenoldopam on intraocular pressure in ocular hypertension

Journal of Clinical Pharmacology

Volumn 37, Issue 4, 1997, Pages 312-320

  Everitt, Daniel E ^a,b,d   Boike, Steven C ^a,d   Piltz Seymour, Jody R ^c,d   VanCoevorden, Rosita ^c   Audet, Patricia ^a,b,d   Zariffa, Nevine ^a,d   Jorkasky, Diane ^a,b,d  

^a PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR STIMULATING AGENT; FENOLDOPAM; PLACEBO;

ADULT; AGED; AQUEOUS HUMOR FORMATION; AQUEOUS HUMOR OUTFLOW; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; MALE; OPEN ANGLE GLAUCOMA; RANDOMIZED CONTROLLED TRIAL; RETINA BLOOD FLOW; RETINA MACULA LUTEA; VISUAL FIELD;

EID: 0030945523     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1997.tb04308.x     Document Type: Article

References (22)

1. Shusterman NH, Elliot WJ, White WB: Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive subjects with impaired renal function. Am J Med 1993; 95:161-168.
2. Elibol O, Guler C, Yuksel N: The effects of dopamine, halperidol and bromocriptine on intraocular pressure (abstract). Int Ophthalmol 1992; 16:343.
3. Virno M, De Gregorio F, Grechi G, Da Dalt S: Dopamine, dopaminergic drugs and ocular hypertension. Int Ophthalmol 1992; 16:349-353.
4. Mekki Q, Turner P: Stimulation of dopamine receptors (type 2) lowers human intraocular pressure. Br J Ophthalmol 1985; 69:909-910.
5. Al-Sereiti R, Coakes D, O'Sullivan D, Turner P: A comparison of the ocular hypotensive effect of 0.025% bromocriptine and 0.25% timolol eye drops in normal human volunteers. Br J Clin Pharmacol 1989; 28:443-447.
6. Al-Sereiti M, Quik R, Hedges A, Turner P: Antagonism by domperidone of the ocular hypotensive effect of pergolide. Eur J Clin Pharmacol 1990; 38:461-463.
7. Gever O, Robinson D, Lazar M: Hypotensive effect of bromocriptine in glaucomatous eyes. J Ocul Pharmacol 1987; 3:291-294.
8. Mekki Q, Hassam S, Turner P: Bromocriptine lowers intraocular pressure without affecting blood pressure. Lancet 1983; 2:1250-1252.
9. Potter D, Burke J, Ogidigben M: Ocular effects of the dopamine DA-2 agonist (Ha-118) in cats and rabbits. J Auton Pharmac 1990; 10:153-161.
10. Elliot W, Karnezis T, Silverman R, Geanon J, Tripathi R, Murphy M: Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans. Clin Pharmacol Ther 1991; 13:285-293.
11. Karnezis T, Murphy M, Weber R, Nelson K, Tripath B, Tripathi R: Effects of selective dopamine-1 receptor activation on intraocular pressure in man. Exp Eye Res 1988; 47:689-697.
12. Piltz J, Stone R, Audet P, Boike S, Everitt D, Shusterman N, Jorkasky D: Fenoldopam, a selective dopamine 1 receptor agonist, raises intraocular pressure (abstract). Invest Ophthalmol Vis Sci 1992; 33(suppl):1121.
13. Calne D: Treatment of Parkinson's disease. N Engl J Med 1993; 329:1021-1027.
14. Mancino R, Cerulli L, Ricci A, Amenta F: Direct demonstration of dopamine D-1-like receptor sites in the ciliary body of rabbit eye by light microscope autoradiography. Arch Pharmacol 1992; 346:644-648.
15. Elena PP, Denis, P, Kosina-Boix M, Lapalus P: Dopamine receptors in rabbit and rat eye: Characterization and localization of DA1 and DA2 binding sites. Curr Eye Res 1989; 8:75-83.
16. Gupta N, Cynader MS, Drance SM: Neuroactive molecules -recent advances and future prospects. In, Drance SM, Van Buskirk EM, Neufeld AH (eds.): Pharmacology of Glaucoma. Baltimore: Williams & Wilkins, 1992; 222-223.
17. Karnezis A, Tripathi B, Dawson G, Murphy M, Tripathi R: Effects of dopamine activation on the level of cyclic AMP in the trabecular meshwork. Invest Ophthamol Vis Sci 1989; 30:1090-1094.
18. Ritch R, Shields MB, Krupin T: The Glaucomas. St. Louis: CV Mosby, 1989; 841.
19. Chiou C, Chen Y: Effects of antiglaucoma drugs on the ocular blood flow in ocular hypertensive rabbits. J Ocul Pharmacol 1993; 9:13-23.
20. Hong SJ, Chiou C: Effects of dopamine agonists and antagonists on pulsatile blood flow of ocular hypertensive rabbits. J Ocul Pharmacol 1993; 9:117-124.
21. Chiou G, Chen Y: Effects of dopamine agonist, bromocriptine. and some dopamine antagoists on ocular blood flow. J Ocul Pharmacol 1992; 8:285-294.
22. Grunwald JE, Zinn H: The acute effect of oral acetazolamide on macular blood flow. Inv Ophth Vis Sci 1992; 33:504-507.